MENU
+Compare
CRMD
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$6.07
Change
-$0.09 (-1.46%)
Capitalization
400.87M

CRMD CorMedix Forecast, Technical & Fundamental Analysis

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases... Show more

CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CRMD with price predictions
Mar 31, 2025

CRMD's RSI Oscillator remains in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRMD advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CRMD as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CRMD turned negative on March 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

CRMD moved below its 50-day moving average on March 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CRMD crossed bearishly below the 50-day moving average on March 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRMD entered a downward trend on March 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.673) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (8.217) is also within normal values, averaging (255.565).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CRMD is expected to report earnings to fall 29.55% to 15 cents per share on May 08

CorMedix CRMD Stock Earnings Reports
Q1'25
Est.
$0.16
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.06
Q2'24
Est.
$-0.25
Q1'24
Beat
by $0.01
The last earnings report on March 25 showed earnings per share of 21 cents, beating the estimate of 17 cents. With 1.22M shares outstanding, the current market capitalization sits at 400.87M.
A.I. Advisor
published General Information

General Information

a developer of medical devices for cardiovascular and kidney diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
300 Connell Drive
Phone
+1 908 517-9500
Employees
83
Web
https://www.cormedix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNAX21.020.16
+0.77%
MFS Equity Income A
SLADX37.980.16
+0.42%
Selected American Shares D
RYCKX32.37N/A
N/A
Rydex S&P MidCap 400 Pure Growth C
AMVRX15.58N/A
N/A
American Century Mid Cap Value R
DCFGX30.06-0.08
-0.27%
Dunham Focused Large Cap Growth C

CRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-8.20%
MURA - CRMD
49%
Loosely correlated
+6.78%
ARTL - CRMD
33%
Poorly correlated
-6.91%
HOTH - CRMD
32%
Poorly correlated
-2.91%
RLYB - CRMD
32%
Poorly correlated
+2.25%
XLO - CRMD
31%
Poorly correlated
-2.90%
More